Which has better earnings & valuation, KIDS or ATRC?

AtriCure has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OrthoPediatrics $236.35M 2.50 -$39.65M -$1.68 N/A AtriCure $534.53M 4.99 -$11.45M $0.21 249.81

Does the media refer more to KIDS or ATRC?

In the previous week, OrthoPediatrics had 3 more articles in the media than AtriCure. MarketBeat recorded 20 mentions for OrthoPediatrics and 17 mentions for AtriCure. AtriCure's average media sentiment score of 1.09 beat OrthoPediatrics' score of 0.58 indicating that AtriCure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 8 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to KIDS or BFLY?

In the previous week, OrthoPediatrics had 16 more articles in the media than Butterfly Network. MarketBeat recorded 20 mentions for OrthoPediatrics and 4 mentions for Butterfly Network. OrthoPediatrics' average media sentiment score of 0.58 beat Butterfly Network's score of 0.39 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor KIDS or ESTA?

In the previous week, OrthoPediatrics had 14 more articles in the media than Establishment Labs. MarketBeat recorded 20 mentions for OrthoPediatrics and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.97 beat OrthoPediatrics' score of 0.58 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer NVCR or KIDS?

In the previous week, OrthoPediatrics had 14 more articles in the media than NovoCure. MarketBeat recorded 20 mentions for OrthoPediatrics and 6 mentions for NovoCure. OrthoPediatrics' average media sentiment score of 0.58 beat NovoCure's score of -0.16 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LMAT or KIDS?

In the previous week, OrthoPediatrics had 12 more articles in the media than LeMaitre Vascular. MarketBeat recorded 20 mentions for OrthoPediatrics and 8 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.27 beat OrthoPediatrics' score of 0.58 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

OrthoPediatrics (KIDS) Competitors

$22.59 -0.21 (-0.92%)

As of 09/3/2026 04:00 PM Eastern

Compare

KIDS vs. ATRC, BFLY, ESTA, NVCR, and LMAT

Should you buy OrthoPediatrics stock or one of its competitors? OrthoPediatrics's main competitors and comparable companies include AtriCure (ATRC), Butterfly Network (BFLY), Establishment Labs (ESTA), NovoCure (NVCR), and LeMaitre Vascular (LMAT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does OrthoPediatrics compare to AtriCure?

OrthoPediatrics (NASDAQ:KIDS) and AtriCure (NASDAQ:ATRC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

AtriCure has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.50	-$39.65M	-$1.68	N/A
AtriCure	$534.53M	4.99	-$11.45M	$0.21	249.81

OrthoPediatrics presently has a consensus price target of $26.44, indicating a potential upside of 17.06%. AtriCure has a consensus price target of $52.00, indicating a potential downside of 0.88%. Given OrthoPediatrics' higher probable upside, equities research analysts clearly believe OrthoPediatrics is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
AtriCure	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by insiders. Comparatively, 4.0% of AtriCure shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AtriCure has a net margin of 1.85% compared to OrthoPediatrics' net margin of -15.72%. AtriCure's return on equity of 2.34% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
AtriCure	1.85%	2.34%	1.77%

In the previous week, OrthoPediatrics had 3 more articles in the media than AtriCure. MarketBeat recorded 20 mentions for OrthoPediatrics and 17 mentions for AtriCure. AtriCure's average media sentiment score of 1.09 beat OrthoPediatrics' score of 0.58 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	8 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

Summary

AtriCure beats OrthoPediatrics on 13 of the 17 factors compared between the two stocks.

How does OrthoPediatrics compare to Butterfly Network?

OrthoPediatrics (NASDAQ:KIDS) and Butterfly Network (NYSE:BFLY) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

OrthoPediatrics presently has a consensus price target of $26.44, indicating a potential upside of 17.06%. Butterfly Network has a consensus price target of $5.56, indicating a potential downside of 23.38%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, equities research analysts plainly believe OrthoPediatrics is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, Butterfly Network has a beta of 2.08, indicating that its share price is 108% more volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.50	-$39.65M	-$1.68	N/A
Butterfly Network	$97.61M	19.81	-$77.06M	-$0.29	N/A

OrthoPediatrics has a net margin of -15.72% compared to Butterfly Network's net margin of -66.74%. OrthoPediatrics' return on equity of -8.10% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Butterfly Network	-66.74%	-33.99%	-22.96%

In the previous week, OrthoPediatrics had 16 more articles in the media than Butterfly Network. MarketBeat recorded 20 mentions for OrthoPediatrics and 4 mentions for Butterfly Network. OrthoPediatrics' average media sentiment score of 0.58 beat Butterfly Network's score of 0.39 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Butterfly Network	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 37.9% of Butterfly Network shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by company insiders. Comparatively, 22.0% of Butterfly Network shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

OrthoPediatrics beats Butterfly Network on 13 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to Establishment Labs?

OrthoPediatrics (NASDAQ:KIDS) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

OrthoPediatrics currently has a consensus target price of $26.44, suggesting a potential upside of 17.06%. Establishment Labs has a consensus target price of $100.25, suggesting a potential upside of 38.66%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

OrthoPediatrics has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.50	-$39.65M	-$1.68	N/A
Establishment Labs	$211.08M	10.21	-$51.06M	-$1.31	N/A

In the previous week, OrthoPediatrics had 14 more articles in the media than Establishment Labs. MarketBeat recorded 20 mentions for OrthoPediatrics and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.97 beat OrthoPediatrics' score of 0.58 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics has a net margin of -15.72% compared to Establishment Labs' net margin of -15.82%. OrthoPediatrics' return on equity of -8.10% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Establishment Labs	-15.82%	-196.69%	-10.73%

OrthoPediatrics has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by company insiders. Comparatively, 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

OrthoPediatrics beats Establishment Labs on 9 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to NovoCure?

NovoCure (NASDAQ:NVCR) and OrthoPediatrics (NASDAQ:KIDS) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

In the previous week, OrthoPediatrics had 14 more articles in the media than NovoCure. MarketBeat recorded 20 mentions for OrthoPediatrics and 6 mentions for NovoCure. OrthoPediatrics' average media sentiment score of 0.58 beat NovoCure's score of -0.16 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NovoCure	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics has a net margin of -15.72% compared to NovoCure's net margin of -21.25%. OrthoPediatrics' return on equity of -8.10% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NovoCure	-21.25%	-44.00%	-15.85%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

OrthoPediatrics has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NovoCure	$655.35M	3.13	-$136.23M	-$1.30	N/A
OrthoPediatrics	$236.35M	2.50	-$39.65M	-$1.68	N/A

84.6% of NovoCure shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 6.6% of NovoCure shares are owned by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

NovoCure currently has a consensus price target of $21.20, suggesting a potential upside of 20.18%. OrthoPediatrics has a consensus price target of $26.44, suggesting a potential upside of 17.06%. Given NovoCure's higher probable upside, research analysts clearly believe NovoCure is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovoCure	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

NovoCure has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

Summary

OrthoPediatrics beats NovoCure on 10 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.

LeMaitre Vascular presently has a consensus target price of $110.60, indicating a potential upside of 37.41%. OrthoPediatrics has a consensus target price of $26.44, indicating a potential upside of 17.06%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

LeMaitre Vascular has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market.

In the previous week, OrthoPediatrics had 12 more articles in the media than LeMaitre Vascular. MarketBeat recorded 20 mentions for OrthoPediatrics and 8 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.27 beat OrthoPediatrics' score of 0.58 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LeMaitre Vascular has a net margin of 25.02% compared to OrthoPediatrics' net margin of -15.72%. LeMaitre Vascular's return on equity of 15.63% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	25.02%	15.63%	10.06%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

LeMaitre Vascular has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	7.38	$57.73M	$2.85	28.24
OrthoPediatrics	$236.35M	2.50	-$39.65M	-$1.68	N/A

Summary

LeMaitre Vascular beats OrthoPediatrics on 11 of the 16 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KIDS vs. The Competition

Export

Metric	OrthoPediatrics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$595.30M	$5.81B	$7.26B	$12.73B
Dividend Yield	N/A	1.76%	2.53%	8.86%
P/E Ratio	-13.45	25.92	273.29	25.38
Price / Sales	2.50	73.28	613.45	97.56
Price / Cash	137.11	33.14	77.82	52.26
Price / Book	1.72	6.04	12.89	6.14
Net Income	-$39.65M	$150.03M	$3.47B	$349.01M
7 Day Performance	-4.48%	-1.32%	0.60%	-0.27%
1 Month Performance	8.19%	1.28%	5.73%	0.68%
1 Year Performance	9.08%	9.88%	25.35%	14.84%

OrthoPediatrics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KIDS OrthoPediatrics	3.1999 of 5 stars	$22.59 -0.9%	$26.44 +17.1%	+8.1%	$595.30M	$236.35M	N/A	200	Insider Trade
ATRC AtriCure	2.8358 of 5 stars	$48.68 -1.2%	$48.63 -0.1%	+50.9%	$2.51B	$534.53M	231.82	1,300	Positive News Analyst Forecast
BFLY Butterfly Network	1.2063 of 5 stars	$9.06 +1.2%	$5.56 -38.6%	+382.4%	$2.38B	$97.61M	N/A	460
ESTA Establishment Labs	3.8396 of 5 stars	$72.15 +0.1%	$100.25 +38.9%	+88.4%	$2.15B	$211.08M	N/A	1,004	Analyst Forecast
NVCR NovoCure	2.7191 of 5 stars	$17.62 +5.1%	$21.20 +20.3%	+46.0%	$1.95B	$655.35M	N/A	1,605	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KIDS) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OrthoPediatrics (KIDS) Competitors

KIDS vs. ATRC, BFLY, ESTA, NVCR, and LMAT

How does OrthoPediatrics compare to AtriCure?

Summary

How does OrthoPediatrics compare to Butterfly Network?

Summary

How does OrthoPediatrics compare to Establishment Labs?

Summary

How does OrthoPediatrics compare to NovoCure?

Summary

How does OrthoPediatrics compare to LeMaitre Vascular?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OrthoPediatrics (KIDS) Competitors

KIDS vs. ATRC, BFLY, ESTA, NVCR, and LMAT

How does OrthoPediatrics compare to AtriCure?

Which has better earnings & valuation, KIDS or ATRC?

Do analysts rate KIDS or ATRC?

Do institutionals & insiders believe in KIDS or ATRC?

Is KIDS or ATRC more profitable?

Does the media refer more to KIDS or ATRC?

Which has more volatility & risk, KIDS or ATRC?

Summary

How does OrthoPediatrics compare to Butterfly Network?

Do analysts prefer KIDS or BFLY?

Which has more volatility & risk, KIDS or BFLY?

Which has preferable earnings & valuation, KIDS or BFLY?

Is KIDS or BFLY more profitable?

Does the media refer more to KIDS or BFLY?

Do institutionals & insiders believe in KIDS or BFLY?

Summary

How does OrthoPediatrics compare to Establishment Labs?

Do analysts recommend KIDS or ESTA?

Which has better earnings and valuation, KIDS or ESTA?

Does the media favor KIDS or ESTA?

Is KIDS or ESTA more profitable?

Which has more volatility and risk, KIDS or ESTA?

Do institutionals & insiders have more ownership in KIDS or ESTA?

Summary

How does OrthoPediatrics compare to NovoCure?

Does the media prefer NVCR or KIDS?

Is NVCR or KIDS more profitable?

Which has better earnings & valuation, NVCR or KIDS?

Do institutionals & insiders hold more shares of NVCR or KIDS?

Do analysts rate NVCR or KIDS?

Which has more volatility & risk, NVCR or KIDS?

Summary

How does OrthoPediatrics compare to LeMaitre Vascular?

Do analysts rate LMAT or KIDS?

Do insiders and institutionals believe in LMAT or KIDS?

Which has more volatility and risk, LMAT or KIDS?

Does the media prefer LMAT or KIDS?

Is LMAT or KIDS more profitable?

Which has preferable earnings & valuation, LMAT or KIDS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools